Role Overview:

The Executive Director of Global Market Access for Pipeline Assets will be responsible for shaping and implementing market access strategies for CSL Behring and CSL Vifor's pipeline assets. This high-impact role is accountable in driving pricing and reimbursement (P&R) readiness at each R&D stage gate decision-making point. It requires strong expertise in Health Economics, R&D interfaces, and a deep understanding of the payer environment in both the US and key international markets.

Key Responsibilities:

• Lead the Market Access pipeline team across all Therapeutic Areas (TAs) within CSL Behring and CSL Vifor. Build, mentor, and lead a high-performing global market access pipeline team, fostering a culture of collaboration, innovation, inclusion, and accountability.
• Serve as a key member of the global Market Access Leadership Team (MALT), contributing to the development and execution of functional strategy, operations, and capability building.
• Accountable for Market Access deliverables at each R&D stage gate, continuously refining and improving standards for these deliverables.
• Collaborate with R&D, Regulatory Affairs, Medical Affairs, Marketing, and other partner functions to influence clinical development programs, ensuring that market access considerations are integrated early in the product lifecycle.
• Analyze and interpret payer landscape, payer policy trends, economic data in both the US and key international markets to inform strategic decision-making for pipeline assets.
• Conduct Early Direct Scientific Advice with US payers and key international Pricing & Reimbursement (P&R) and Health Technology Assessment (HTA) agencies to secure input on clinical trial design and evidence generation, optimizing product profiles for market entry.
• Identify market access opportunities and risks, capture opportunities, mitigate risks through proactive planning, scenario analysis, and stakeholder engagement.
• Develop Market Access Plans (MAP) for early and late-stage development assets, with the purpose to maximize asset lifecycle value, while being responsible for patient access and public health. Update the MAP at each stage gate and major data readout.
• Identify payer value drivers, define payer evidence requirements, and craft compelling payer value propositions (PVPs) and health economic models that demonstrate the clinical and economic value of pipeline assets to payers and other value stakeholders.
• Shape Target Product Profiles (TPPs), clinical trial designs, and Target Product Claims (TPCs) to align with payer value drivers and evidence requirements.
• Proactively and systematically define payer evidence requirements and evidence generation strategies, including real-world evidence (RWE); collaborate with the HEOR Shared Service to ensure high-quality, timely payer evidence generation and dissemination.
• Deliver early Global Value Dossiers (GVDs), update GVD at stage gate and major data readout.
• Provide Market Access estimates for Business Development & Licensing (BD&L) assets.

• At least 15 years of experience in global market access, with a focus on pipeline asset market access strategy, health economics and outcomes research.
• Proven track record of leading and developing high-performing teams in a global, cross-functional environment. A role model of collaboration, innovation, inclusion, and accountability.
• Extensive knowledge and experience at the intersection of market access and R&D.
• In-depth knowledge of global healthcare systems and payer landscapes, particularly in the US and key international markets.
• Proven ability to deliver superior performance across multiple therapeutic areas.
• Advanced degree in Health Economics, Public Health, or a related field; a PhD in Health Economics is strongly preferred.